Clinical progress note: Anti‐amyloid monoclonal antibodies
Click on the article title to read more.
Click on the article title to read more.
Everybody reading this column knows that biopharma is a difficult business. Biology is unfathomably complicated and figuring out how to introduce something into the human…
Vertex AI Search for Healthcare is designed to quickly query a patient’s medical record. Google says the tool will reduce the administrative burden for payers…
Amgen will launch its biosimilar version of Regeneron’s blockbuster eye care drug Eylea following a U.S. appeals court ruling in its favor on Tuesday, an…
Learn how we’re expanding CAD management options for special patient populations through innovative offerings for microvascular disease and abundant clinical trial opportunities for elevated Lp(a)
Join Health Affairs on November 7 for a virtual event highlighting how states have promoted Medicare and Medicaid integration even in the absence of full…
Post-acute COVID-19 syndrome (PACS) has been linked to microvascular endothelial dysfunction as a potential underlying pathomechanism and can manifest even following a mild course of…
Energy vampires can suck the energy out of social situations. Think you’ve encountered one? A psychologist explains the signs to look for and how to…
Stryker Medsurg and Neurotechnology Group President Andy Pierce explains some deals seen as “head-scratchers” when first announced.
The brain-vascular-immune interface has emerged as a dynamic player in brain physiology and disease. We propose integrating vascular risk factors with genetic susceptibility as the…
The easily spreadable virus can affect people of all ages and have huge consequences during winter.